1 / 16

Mark Lynch Clinical Lead Urology CUH

Mark Lynch Clinical Lead Urology CUH. Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk. UTI. ADHERERNCE MECHANISMS FIMBRIAE type I – mannose sensitive, adhere to uroplakins Ia and Ib on urothelium P type – mannose insensitive

Télécharger la présentation

Mark Lynch Clinical Lead Urology CUH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mark LynchClinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk

  2. UTI • ADHERERNCE MECHANISMS • FIMBRIAE • type I – mannose sensitive, adhere to uroplakins Ia and Ib on urothelium • P type – mannose insensitive • Pap (P pili associated with pyelonephritis) – 4 proteins (F, A, G, E) • PapG is receptor component • 3 subtypes (I, II, III) • PapG subtype II associated more with pyelonephritis • PapG subtype III associated more with cystitis

  3. UTIs • UTI • Infection • Complicated or not • Recurrent • Management • Infection and stones – hand in hand

  4. UTIs or cystitis • 30% of women have at least one UTI in their lifetime • Rare in Men – investigate • Recurrent UTIs in women warrant investigation • $1.6Bn / year in US Forman B, Am J Med 2002

  5. UTIs – risk factors • Host immunity vs. Bacterial virulence • Host • Bacterial flora • Immunity and comorbidity • Stasis • Foreign body • Bacterial virulence • Fimbriae and Pili • Antimicrobial resistance

  6. UTI – excluding a cause • Complicated: • Structural or functional abnormality or underlying disease to increase infection… • DM, renal insufficiency • Urological (DxT, childhood Hx), neurological • Pregnancy, voiding dysfunction • All men

  7. UTIs – bacterial resistance • E.Coli and coliforms – 80% • Staph. Sap. – 10% • Klebsiella, Enterobacter, Proteus .. • Note foreign travel • Recent in hospital care Ronald, A Am J Med 2002

  8. Recurrent UTI - referral • UTIs that fail to respond to appropriate antibiotics. • >2 UTI in 6 months • >3 in one year • In reality – balance of risk and impact

  9. Recurrent UTI - management • History (Current, childhood, family, risk factors…smoking) • Examination – including pelvic examination • MSU, bladder diary, GFR, USS, Flexi / Cystoscopy +EUA • Pathology: Anatomical, functional, TCC, Stones

  10. Recurrent UTI - management

  11. UTIs • Very common • Confirm the infection and sensitivities • Refer complicated and/or recurrent UTIs • Beware red flags • Multi modality approach to treatment • Questions… • UTIs… • Pathways… • Anything else Urological…

  12. Renal Colic and Stones • 10% risk, 50% recurrence risk at 10 years • Risk factors include: • Geography • Diet • Anatomical • M>F • Fluid intake • Genetics (Cysteinuria)

  13. Renal Colic and Stones at CUH • Pain relief • History • Examination • Gold standard ED management • CT KUB • Early diagnosis • Early treatment • Stone clinic F/U • Access to tertiary care

  14. Renal Colic and stones at CUH • CUH • Laser lithotripsy • ESWL • Dedicated stone clinic • Seamless link with SGH • SGH • PCNL • URS (day case)

More Related